|
Impurity HA-2
|
杂质HA-2
|
13257-67-5
|
|
1-
cyclopropylnap
hthalen-2-
amine
|
1-环丙基萘-2-胺
|
2385682-46-0
|
|
Impurity HA-1
|
杂质HA-1
|
32926-43-5
|
|
Oxytocin solution
|
缩宫素溶液
|
50-56-6
|
|
Impurity DA-4
|
杂质DA-4
|
1416793-14-0
|
|
Upadacitinib Impurity 03
|
乌帕替尼杂质03
|
1708997-42-5
|
|
ethyl 8-(2-hydroxybenzamido)octanoate
|
8-(2-羟基苯甲酰胺)辛酸乙酯
|
1027911-46-1
|
|
Isomer Ⅰ of Lansoprolol Hydrochloride
|
盐酸兰地洛尔异构体Ⅰ
|
1253907-83-3
|
|
Selexipag Impurity 12
|
司来帕格杂质12
|
475086-28-3
|
|
Piperacillin EP Impurity S
|
哌拉西林EP杂质S
|
|
|
Vortioxetine Impurity 20
|
沃替西汀杂质20
|
14340-33-1
|
|
Stiripentol Impurity 15
|
司替戊醇杂质15
|
631-65-2
|
|
(R) Ethyl 3- (iodomethyl) hexanoate
|
(R)-3-(碘甲基)己酸乙酯
|
2428577-25-5
|
|
Piperacillin EP Impurity M(sodium salt)
|
哌拉西林EP杂质M(钠盐)
|
|
|
ERYTHROMYCIN IMPURITY A
|
红霉素杂质A
|
82230-93-1
|
|
Hexetidine EP Impurity C
|
海克替啶EP杂质 C
|
141-94-6
|
|
Piperacillin EP Impurity N
|
哌拉西林EP杂质N
|
|
|
Roxadustat Impurity B
|
罗沙司他杂质B
|
708263-68-7
|
|
Beninidipine hydrochloride impurity 5
|
盐酸贝尼地平杂质5
|
39562-27-1
|
|
Vortioxetine Impurity 12
|
沃替西汀杂质12
|
27080-90-6
|
|
Selexipag Impurity 14
|
司来帕格杂质14
|
2010956-45-1
|
|
Vonoprazan Impurity 60
|
沃诺拉赞杂质60
|
2932441-73-9
|
|
Vortioxetine Impurity 15
|
沃替西汀杂质15
|
2925447-38-5
|
|
Upadacitinib Impurity 12
|
乌帕替尼杂质12
|
51814-19-8
|
|
Stiripentol Impurity A
|
司替戊醇杂质A
|
49763-96-4
|
|
Impurity HA-7
|
杂质HA-7
|
62-57-7
|
|
Selexipag Impurity 15
|
司来帕格杂质15
|
475085-57-5
|
|
Diepoxy (hydroxyfluorophenyl) epoxide
|
二环氧(羟基氟苯基)环氧化物
|
873950-17-5
|
|
Beninidipine hydrochloride impurity B
|
盐酸贝尼地平杂质B
|
118935-44-7
|
|
Nifedipine Impurity E
|
硝苯地平杂质E
|
21829-26-5
|
|
Upadacitinib Impurity 04
|
乌帕替尼杂质04
|
1708997-43-6
|
|
Beninidipine hydrochloride impurity 4
|
盐酸贝尼地平杂质4
|
101072-61-1
|
|
Upadacitinib Impurity 10
|
乌帕替尼杂质10
|
2715120-88-8
|
|
Methyl Myristate
|
肉豆蔻酸甲酯
|
124-10-7
|
|
3,4-Dichlorobenzoic acid
|
3，4-二氯苯甲酸
|
51-44-5
|
|
Vonoprazan Impurity 75
|
沃诺拉赞杂质75
|
1224739-02-9
|
|
Etomidate Impurity 16
|
依托咪酯杂质16
|
2374709-47-2
|
|
Isomer Ⅱ of Lansoprolol Hydrochloride
|
盐酸兰地洛尔异构体Ⅱ
|
1253907-85-5
|
|
Selexipag Impurity 16
|
司来帕格杂质16
|
2287345-22-4
|
|
Piperacillin EP Impurity K
|
哌拉西林EP杂质K
|
|
|
Ziprasidone EP Impurity D
|
齐拉西酮EP杂质D
|
1303996-68-0
|
|
Remdesivir triphosphate
|
瑞德西韦三磷酸
|
1355149-45-9
|
|
Impurity DA-2
|
杂质DA-2
|
3082-75-5
|
|
Roxadustat Impurity A
|
罗沙司他杂质A
|
2599284-47-4
|
|
Vortioxetine Impurity 16
|
沃替西汀杂质16
|
36596-75-5
|
|
Beninidipine hydrochloride impurity 13
|
盐酸贝尼地平杂质13
|
3323-73-7
|
|
Isocyclosporine impurity H
|
异环孢素杂质H
|
83602-43-1
|
|
Upadacitinib Impurity 01
|
乌帕替尼杂质01
|
1428243-27-9
|
|
Upadacitinib Impurity 19
|
乌帕替尼杂质19
|
1869118-25-1
|
|
Impurity DA-8
|
杂质DA-8
|
1570206-15-3
|
|
Impurity DA-5
|
杂质DA-5
|
538334-18-8
|
|
Deoxyribonucleic acid sodium salt
|
脱氧核糖核酸钠盐
|
73049-39-5
|
|
Nifedipine Impurity E
|
硝苯地平杂质E
|
39562-75-9
|
|
Nifedipine Impurity 25
|
硝苯地平杂质25
|
76258-20-3
|
|
Vortioxetine Impurity 03
|
沃替西汀杂质03
|
508234-03-5
|
|
Landiolol Hydrochloride
|
盐酸兰地洛尔
|
144481-98-1
|
|
Selexipag Impurity 11
|
司来帕格杂质11
|
2928611-22-5
|
|
Beninidipine hydrochloride impurity E
|
盐酸贝尼地平杂质E
|
74936-72-4
|
|
Vortioxetine Impurity 13
|
沃替西汀杂质13
|
960203-41-2
|
|
Beninidipine hydrochloride impurity 11
|
盐酸贝尼地平杂质11
|
1185304-22-6
|
|
SNAC reference standard
|
SNAC对照品
|
203787-91-1
|
|
Beninidipine hydrochloride impurity 10
|
盐酸贝尼地平杂质10
|
85387-34-4
|
|
Impurity DA-7
|
杂质DA-7
|
850324-83-3
|
|
Isomer Ⅲ of Lansoprolol Hydrochloride
|
盐酸兰地洛尔异构体Ⅲ
|
1253907-81-1
|
|
Vortioxetine Impurity 06
|
沃替西汀杂质06
|
1293342-97-8
|
|
Dicloxacillin Impurity 6
|
双氯西林杂质6
|
1642576-88-2
|
|
Hexetidine EP Impurity B
|
海克替啶EP杂质 B
|
3687-16-9
|
|
ERYTHROMYCIN IMPURITY I
|
红霉素杂质I
|
546-57-6
|
|
(S)-1-Amino-3-chloro-2-propanol hydrochloride
|
利奈唑胺杂质26盐酸盐
|
34839-13-9
|
|
Nifedipine Impurity F
|
硝苯地平杂质F
|
53055-15-5
|
|
Nicardipine hydrochloride EP impurity B
|
盐酸尼卡地平EP杂质B
|
71784-27-5
|
|
Etomidate Impurity 10
|
依托咪酯杂质10
|
66512-37-6
|
|
Kasharin reference substance
|
卡沙仑对照品
|
2037-95-8
|
|
Selexipag Impurity 06
|
司来帕格杂质06
|
475086-95-4
|
|
Piperacillin EP Impurity R
|
哌拉西林EP杂质R
|
|
|
ERYTHROMYCIN IMPURITY C
|
红霉素杂质C
|
41451-91-6
|
|
Formoterol EP Impurity G
|
福莫特罗EP杂质G
|
23239-32-9
|
|
Vortioxetine Impurity 17
|
沃替西汀杂质17
|
1639263-83-4
|
|
Stiripentol Impurity 4
|
司替戊醇杂质4
|
106175-03-5
|
|
Upadacitinib Impurity 16
|
乌帕替尼杂质16
|
1428243-24-6
|
|
Hyaluronidase; Hyaluronidase
|
透明质酸酶;玻璃酸酶
|
9001-54-1
|
|
(3R) -3- ({[(1S) -1-carbamidopropyl] amino} methyl) hexanoate ethyl ester
|
(3R)-3-({[(1S)-1-甲酰胺基
丙基]氨基}甲基)己酸乙酯
|
748760-80-7
|
|
Hexetidine EP Impurity A
|
海克替啶EP杂质A
|
188655-38-1
|
|
Bathocuproinedisulfonic acid disodium salt
|
浴铜灵二磺酸 二钠盐
|
52698-84-7
|
|
Beninidipine hydrochloride impurity 6
|
盐酸贝尼地平杂质6
|
40641-47-2
|
|
Impurity DA-6
|
杂质DA-6
|
123105-87-3
|
|
Piperacillin EP Impurity P
|
哌拉西林EP杂质P
|
|
|
Selexipag Impurity 09
|
司来帕格杂质09
|
2514706-51-3
|
|
Stiripentol Impurity 17
|
司替戊醇杂质17
|
58344-73-3
|
|
Impurities HY-VIII in the raw material of ezetimibe
|
依折麦布原料药杂质HY-VIII
|
2743547-96-6
|
|
2-chloro-4-
cyclopropyl-1-
isothiocyanato
naphthalene
|
2-氯-4-环丙基-1-异硫氰基萘
|
2170177-13-4
|
|
Hydroxyisopropyl epoxide
|
羟基异丙基环氧化物
|
873950-18-6
|
|
2,4-Dichlorobenzoic acid
|
2，4-二氯苯甲酸
|
50-84-0
|
|
Roxadustat Impurity D
|
罗沙司他杂质D
|
1421312-35-7
|
|
Beninidipine hydrochloride impurity D
|
盐酸贝尼地平杂质D
|
91599-78-9
|
|
Nifedipine Impurity D
|
硝苯地平杂质D
|
117177-77-2
|
|
Piperacillin EP Impurity L
|
哌拉西林EP杂质L
|
|
|
Piperacillin EP Impurity F
|
哌拉西林EP杂质F
|
|
|
Selexipag Impurity 04
|
司来帕格杂质04
|
2068134-98-3
|
|
Vortioxetine Impurity 07
|
沃替西汀杂质07
|
2137793-92-9
|